Civik Thomas bought PYXS
February 3, 2026 · Form 4 insider transaction
Civik Thomas bought 690,131 shares of Pyxis Oncology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
690,131
Price
$0.00
Total value
N/A
InsiderCivik Thomas
RoleOfficer, Director
CompanyPyxis Oncology, Inc. (PYXS)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 3, 2026
Filing dateFebruary 5, 2026
Shares owned after690,131
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to this option will vest in 12 equal monthly installments, commencing on the grant date and subject to the reporting person's continued service as Interim Chief Executive Officer through the applicable vesting date.